Association between Charlson Comorbidity Index and polypharmacy: a retrospective database study from Jordan.

Rasha M ArabyatOla M AlazzamSayer I Al-AzzamMohammad B Nusair

Published in: The International journal of pharmacy practice (2021)

Polypharmacy is common among patients in Jordan. Comorbidity is positively, independently and strongly related to polypharmacy. Identifying groups who are at the greatest risk for polypharmacy can help optimize patients' treatment, which can lead to better outcomes and improved quality of life.

Keyphrases

adverse drug
end stage renal disease
ejection fraction
newly diagnosed
emergency department
adipose tissue
patient reported outcomes
combination therapy
electronic health record